Recruiting
Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors
This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.
ClinicalTrials.gov IDNCT06570057
PhaseNA
Enrollment240
SponsorBaqai Institute of Diabetology and Endocrinology
Age20 Years
SexALL
Conditions studied
Type II Diabetes Mellitus
About this study
This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.
Interventions
- Behavioral: Participatory, learning and Action (PLA) Based intervention — An PLA based intervention would be carried out to prepare the Diabetes Mellitus type II patients. The intervention would be carried out for a tentative time of 2 to 3 hours to educate the type II diabetes mellitus. The study participants would be evaluated after completion of 18 months of the intervention. A structured, validated and literature-based assessment checklist will be devised to assess the effectiveness and feasibility of the intervention.
Primary outcomes
- Prevalence of Type II Diabetes Mellitus (18 months)
- Two-year cumulative incidence of Type II Diabetes Mellitus (18 months)
Eligibility information
Inclusion Criteria:
* Individuals aged 20 years and above.
* Participants residing in the randomized clusters of Karachi, Pakistan
* Individuals willing to participate in the study and provide consent.
* Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to participate.
* Participants who can attend the scheduled meetings and interventions as per the study protocol.
Exclusion Criteria:
* Individuals below the age of 20 years.
* Individuals unwilling to provide consent for participation.
* Participants with severe health conditions that may hinder their active involvement in the study.
* Individuals with non-compliance with research protocols
Study locations
- Baqai Institute of Diabetology and Endocrinology (BIDE), Karachi, Sindh 74600 Pakistan
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.